ARCHX
Price
$18.01
Change
-$0.10 (-0.55%)
Updated
Jun 13 closing price
Net Assets
53.2M
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

ARCHX vs RLBGX

Header iconARCHX vs RLBGX Comparison
Open Charts ARCHX vs RLBGXBanner chart's image
Archer Balanced
Price$18.01
Change-$0.10 (-0.55%)
VolumeN/A
Net Assets53.2M
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
ARCHX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARCHX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCHX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. ARCHX (53.2M). RLBGX pays higher dividends than ARCHX: RLBGX (2.23) vs ARCHX (1.28). ARCHX was incepted earlier than RLBGX: ARCHX (20 years) vs RLBGX (16 years). ARCHX (1.31) is less costly to investors than RLBGX (0.25). RLBGX is a more actively managed with annual turnover of: 44.00 vs. ARCHX (11.69). RLBGX has a lower initial minimum investment than ARCHX: RLBGX (250) vs ARCHX (2500). RLBGX (5.63) and ARCHX (5.55) have marching annual gain over last year. ARCHX return over 5 years is better than : 48.98 vs. RLBGX (40.35).
ARCHXRLBGXARCHX / RLBGX
Total Expense Ratio1.210.25484%
Annual Report Gross Expense Ratio1.310.25524%
Fund Existence20 years16 years-
Gain YTD3.0304.59266%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets53.2M244B0%
Annual Yield % from dividends1.282.2357%
Returns for 1 year5.555.6398%
Returns for 3 years28.7833.7885%
Returns for 5 years48.9840.35121%
Returns for 10 years72.9360.87120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp